Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Enjoy this offer
* See conditions under "Our services"

Valuation: GENFIT

Market Cap 422M 487M 389M 365M 681M 46.59B 696M 4.64B 1.8B 22.46B 1.83B 1.79B 78.09B P/E Ratio 2025
-3.06x
P/E Ratio 2026 * 44.6x
Enterprise Value 368M 424M 339M 317M 593M 40.55B 605M 4.04B 1.56B 19.55B 1.59B 1.56B 67.97B EV / Sales 2025
2.34x
EV / Sales 2026 * 3.94x
Free-Float
86.88%
Yield 2025 *
-
Yield 2026 * -
1 day+4.01%
1 week-3.08%
Current month+0.23%
1 month-0.45%
3 months-1.62%
6 months+69.62%
Current year+67.52%
1 week 8.15
Extreme 8.15
9.76
1 month 8.15
Extreme 8.15
9.76
Current year 5.05
Extreme 5.05
9.76
1 year 3.05
Extreme 3.048
9.76
3 years 2.62
Extreme 2.62
9.76
5 years 2.62
Extreme 2.62
9.76
10 years 2.62
Extreme 2.62
35.65
Manager TitleAgeSince
Chief Executive Officer 58 2019-09-15
Director of Finance/CFO 52 2021-04-21
Chief Tech/Sci/R&D Officer - 2025-11-26
Director TitleAgeSince
Chairman 70 2017-06-15
Director/Board Member 54 1999-09-14
Director/Board Member 58 2017-06-15
Date Insider Type Main position Quantity % Market Cap.
03-04Fiscal year

Chief Operating Officer

11,250 0.0225%
03-04Sell

Chief Operating Officer

7,083 0.0142%
03-04Fiscal year

Chief Operating Officer

10,625 0.0212%
Change 5-day change 1-year change 3-year change Capi.($)
+4.01%-3.08%+132.11%+120.50% 488M
-1.40%+0.12%-14.73%-12.42% 43.68B
+3.13%-4.10%+266.02%+489.89% 30.65B
-2.11%-4.49%+12.38%-15.76% 30.4B
-1.29%-7.08%-0.88%+22.00% 29.31B
-0.66%-7.13%+7.59%+12.76% 24.2B
+1.38%+2.76%+55.92%+116.20% 13.3B
+3.69%-0.78% - - 13.03B
-1.65%-1.08%+7.92%+8.03% 13.21B
+0.83%-1.65%+104.17%+77.49% 12.12B
Average +0.68%-0.95%+63.39%+90.96% 21.04B
Weighted average by Cap. +0.05%-1.44%+51.79%+89.17%

Financials

2025 2026 *
Net sales 66.82M 76.99M 61.59M 57.71M 108M 7.37B 110M 735M 284M 3.55B 289M 283M 12.36B 95.2M 110M 87.75M 82.22M 154M 10.5B 157M 1.05B 405M 5.06B 412M 403M 17.6B
Net income -8.3M -9.57M -7.65M -7.17M -13.4M -916M -13.68M -91.29M -35.34M -442M -35.91M -35.14M -1.54B 18.31M 21.09M 16.87M 15.81M 29.54M 2.02B 30.16M 201M 77.93M 974M 79.19M 77.48M 3.39B
Net Debt -54.72M -63.06M -50.44M -47.26M -88.31M -6.04B -90.14M -602M -233M -2.91B -237M -232M -10.12B -46.87M -54.01M -43.2M -40.48M -75.63M -5.17B -77.21M -515M -200M -2.49B -203M -198M -8.67B
Logo GENFIT
GENFIT is a biopharmaceutical company in late-stage development focused on the discovery and development of innovative therapeutic and diagnostic solutions in the field of liver diseases, particularly of metabolic origin, where unmet medical needs are considerable, in particular due to a lack of approved treatments. GENFIT is a leading innovator in the field of nuclear receptor-based drug discovery with a rich history and a solid scientific heritage spanning nearly two decades. The company has offices in Lille, Paris, Zurich and Cambridge, MA (USA).
Employees
188
Date Price Change Volume
26-06-11 8.820 +4.01% 210,456
26-06-10 8.480 0.00% 228,955
26-06-09 8.480 -3.31% 367,059
26-06-08 8.770 0.00% 307,550
26-06-05 8.770 -3.63% 711,938
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
8.480EUR
Average target price
14.00EUR
Spread / Average Target
+65.09%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. GNFT Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!